Aspen buys GlaxoSmithKline? for R2.1bn: Asief Mohamed

How does this deal tie up with Aspen’s existing business? GUGULETHU MFUPHI: South Africa’s Aspen Healthcare share price shot up by 6% today after it bought several over-the-counter brands from GlaxoSmithKline for over R2bn. To get more perspective on the deal we speak we speak to Asief Mohamed, who’s the chief investment officer at AEON Investment [...]

2017-10-17T16:31:47+00:00April 20th, 2012|